Tag: animal drug compounding market size

  • Animal Drug Compounding Market Overview 2024: Size, Growth Drivers, and Major Segments

    Animal Drug Compounding Market Overview 2024: Size, Growth Drivers, and Major Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Animal Drug Compounding Market for the Period 2024 to 2033?

    There’s been notable growth in the animal drug compounding market in recent times. The market, which is projected to increase from $1.56 billion in 2023 to $1.69 billion in 2024, is anticipated to have a compound annual growth rate (CAGR) of 8.1%. The past growth can be ascribed to regulatory landscape alterations, established veterinary practices, heightened market awareness, scarcity of commercial choices, and veterinary cooperation.

    The market size for animal drug compounding is predicted to experience significant expansion in the upcoming years, with projections indicating growth to $2.23 billion by 2028, with a compound annual growth rate (CAGR) of 7.2%. Anticipated growth within the predicted period can be linked to numerous factors including changes in regulatory landscape, trends in pet ownership, advancements in specialized veterinary care, the expansion of global veterinary services, and progress in veterinary medicine. The forecast period is also expected to witness trends like emphasis on flavor and palatability, demand surge for specialized dosage forms, collaboration between vets and compounding pharmacists, focus on pain management solutions, and an increasing role in veterinary hospice care.

    Claim Your Free Sample of the Global Animal Drug Compounding Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9964&type=smp

    What Factors Are Responsible for the Growth of the animal drug compounding Market?

    The animal drug compounding market stands to benefit from the trend of increased animal adoption rates. Adopting animals typically involves sourcing them from rescue centers instead of traditional venues such as pet shops or breeders. It is not uncommon for these adopted pets to have pre-existing health issues or a need for medication unavailable in mass-produced forms, hence fuelling the demand for tailored pet medication. Thus, as pet owners lean towards personalized medication for their adopted pets, the demand for animal drug compounding grows. Illustratively, Chewy, Inc., an online retailer of pet products based in the US, noted that about 977,202 pets were adopted in the US in 2021, pushing the adoption rate to a six-year high of 61%. Additionally, a November 2022 national survey of pets and people from Animal Medicines Australia (AMA), unveiled that 48% of Australian homes had dogs in 2022, a growth from 40% in 2019. This higher rate of animal adoption is stimulating the growth of the animal drug compounding market.

    Which Segments Are Important for Insight into the Animal Drug Compounding Market?

    1) By Animal Type: Companion Animals, Livestock Animals

    2) By Product: Anti-infective Agents, Anti-inflammatory Agents, Hormones And Substitutes, CNS Agents, Other Products

    3) By Route of Administration: Oral, Injectable, Topical, Other Routes Of Administration

    4) By Application: Veterinary Hospitals, Veterinary Clinics, Veterinary Diagnostic Centers

    What Are the Significant Trends Reshaping the Animal Drug Compounding Sector?

    Key players in the animal drug compounding market, such as Evonik and Revivo BioSystems, are directing their efforts into animal drug compounding technology development to augment their market revenues. The organ-on-a-chip technology, pioneered by Revivo BioSystems, enables simulation of human skin interaction with the material under test – a process that promises to be faster, more reliable, and cost-effective compared to traditional animal testing. For example, Evonik, a specialty chemicals firm based in Germany, made a significant monetary contribution to Revivo BioSystems, a Singapore-based startup that has innovated a realistic 4D model of human skin for the analysis of chemical, cosmetic, and pharmaceutical compounds in December 2021. This move aligns with Evonik’s pledge to back new technologies that are alternatives to conventional research methods and champion practices that are more sustainable and ethically responsible.

    Order Now for Fast Delivery of Your Animal Drug Compounding Market Report!

    https://www.thebusinessresearchcompany.com/report/animal-drug-compounding-global-market-report

    Which Regions Are Essential for the Growth of the Animal Drug Compounding Market?

    North America was the largest region in the animal drug compounding market in 2023. The regions covered in the animal drug compounding market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Animal Drug Compounding Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the animal drug compounding market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Animal Drug Compounding Market Include

    1. Animal Drug Compounding Market Executive Summary

    2. Animal Drug Compounding Market Segments

    3. Animal Drug Compounding Market Size And Template Market Growth Rate

    4. Key Animal Drug Compounding Market Trends

    5. Major Animal Drug Compounding Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Animal Drug Compounding Market

    26. Top Animal Drug Compounding Companies

    27. Animal Drug Compounding Market Opportunities And Strategies

    28. Animal Drug Compounding Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Animal Drug Compounding Market Key Insights 2024-2033

    Global Animal Drug Compounding Market Key Insights 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Animal Drug Compounding Global Market Report 2024, the animal drug compounding market is expected to show promising growth in the forecast period.

    Striking Market Growth and Projections
    The animal drug compounding market has demonstrated robust growth, with projections indicating an increase from $1.56 billion in 2023 to $1.69 billion in 2024, showcasing a compound annual growth rate (CAGR) of 8.1%. This expansion is primarily fueled by regulatory advancements, evolving veterinary practices, increased market awareness, limited commercial options, and collaborative efforts between veterinarians and compounding pharmacists.

    Anticipated Expansion and Contributing Factors

    1. Promising Growth: Forecasts predict a rise to $2.23 billion by 2028, maintaining a steady compound annual growth rate (CAGR) of 7.2%.
    2. Driving Forces: Regulatory developments, pet ownership trends, specialized veterinary care, globalization of veterinary services, and advancements in veterinary medicine are key factors driving growth.
    3. Emerging Trends: Focus on flavoring and palatability, demand for specialized dosage forms, collaboration between veterinarians and compounding pharmacists, emphasis on pain management solutions, and growing role in veterinary hospice care are prominent trends.

    Pets’ Expenditure Fueling Growth
    The escalating expenditure on pets serves as a pivotal driver propelling the growth of the animal drug compounding market. Rising pet expenditure encompasses various expenses related to pet care, including medications tailored to address individual animal needs. Notably, the American Pet Products Association reported a significant surge in total pet industry expenditures in the US, reaching $123.6 billion in 2023, indicating a growing demand for specialized veterinary medications.

    Innovative Investments Advancing Compounding Technologies

    1. Investment in Technologies: Major players are investing in innovative animal drug compounding technologies to drive market revenues.
    2. Revolutionary Solutions: Evonik’s investment in Revivo BioSystems, a startup specializing in organ-on-a-chip technology, highlights a shift towards more sustainable and ethical research practices.
    3. Alternative to Animal Testing: Organ-on-a-chip technology simulates human skin interaction, offering a quicker, more reliable, and cost-efficient alternative to traditional animal testing methods.

    Strategic Acquisitions Expanding Market Reach

    1. Partners Group’s Acquisition of Wedgewood Pharmacy: Partners Group’s strategic acquisition of Wedgewood Pharmacy for $700 million in April 2021 aimed to bolster the company’s presence and services in the animal health market.
    2. Expansion Initiatives: Wedgewood Pharmacy, a leading US-based compounding pharmacy, offers an array of animal drug compounding services, contributing to market growth and diversification.

    Market Segmentation and Regional Dynamics

    1. By Animal Type: Companion Animals and Livestock Animals cater to diverse veterinary needs.
    2. By Product: Anti-infective Agents, Anti-inflammatory Agents, Hormones and Substitutes, CNS Agents, and other products offer tailored solutions.
    3. By Route of Administration: Oral, Injectable, Topical, and other routes of administration ensure flexible medication delivery.
    4. By Application: Veterinary Hospitals, Veterinary Clinics, and Veterinary Diagnostic Centers address varied healthcare settings.

    Regional Insights: North America Leading the Way

    1. Dominance of North America: North America emerged as the largest region in the animal drug compounding market in 2023, underscoring its significant role in driving market growth and innovation.

    Conclusion
    The animal drug compounding market’s trajectory reflects a dynamic landscape driven by technological advancements, strategic investments, and evolving consumer preferences. As pet ownership trends continue to rise and regulatory frameworks evolve, there’s an increased demand for specialized veterinary medications tailored to individual animal needs. Collaborative efforts between veterinarians and compounding pharmacists are pivotal in addressing the diverse healthcare needs of companion and livestock animals. With a focus on innovation and expansion, the animal drug compounding market is poised for sustained growth and transformative developments in the years to come.

    View More On The Animal Drug Compounding Market Report 2024 – https://www.thebusinessresearchcompany.com/report/animal-drug-compounding-global-market-report

    Request A Sample Of The Global Animal Drug Compounding Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9964&type=smp